StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$2.06+0.10 (+5.10%)

Close on Nov 18, 2026Market cap $19.86MP/E –Yield –

Edesa Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Edesa Biotech's market cap was $21.39M on Nov 11, 2026, against $12.50M a year earlier. Over the last 5 years it ranged from $5.46M to $523.96M, with a median of $24.76M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$21.39M+110.9%
2025Dec 31, 2025$10.14M+85.9%
2024Dec 31, 2024$5.46M-61.2%
2023Dec 29, 2023$14.05M-60.9%
2022Dec 30, 2022$35.99M-93.1%
2021Dec 31, 2021$523.96M+83.2%
2020Dec 31, 2020$286.04M+32.8%
2019Dec 31, 2019$215.37M+5.7%
2018Dec 31, 2018$203.73M-43.1%
2017Dec 29, 2017$357.92M-58.6%
2016Dec 30, 2016$864.17M-59.5%
2015Dec 31, 2015$2.13B-44.1%
2014Dec 31, 2014$3.81B-11.0%
2013Dec 31, 2013$4.28B+703.4%
2012Dec 31, 2012$533.19M–

More Edesa Biotech figures

See a number that looks wrong?